Impact of the COVID-19 pandemic on tuberculosis laboratory services in Europe

Vladyslav Nikolayevskyy; Yen Holicka; Dick van Soolingen; Marieke J van der Werf; Csaba Ködmön; Elena Surkova; Doris Hillemann; Ramona Groenheit; ERLTB-Net-2 study participants; Daniela Cirillo

doi:10.1183/13993003.03890-2020

Impact of the COVID-19 pandemic on tuberculosis laboratory services in Europe

Eur Respir J. 2021 Jan 5;57(1):2003890. doi: 10.1183/13993003.03890-2020. Print 2021 Jan.

Affiliations

¹ Public Health England, London, UK.
² Imperial College London, London, UK.
³ National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
⁴ European Centre for Disease Prevention and Control, Solna, Sweden.
⁵ Royal Brompton Hospital, London, UK.
⁶ National Reference Centre for Mycobacteria, Borstel, Germany.
⁷ Public Health Agency of Sweden, Stockholm, Sweden.
⁸ San Raffaele Scientific Institute, Milan, Italy.

Abstract

Sustainable support from healthcare bodies is needed to preserve TB laboratory capacity, and maintain personnel and skills, to minimise negative effects of the COVID-19 pandemic on laboratory services severely disrupted in the early months of pandemic https://bit.ly/38camaL

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

COVID-19 / epidemiology*
COVID-19 / prevention & control
COVID-19 / transmission
Diagnostic Services / organization & administration*
Europe
Humans
Tuberculosis / diagnosis*
Tuberculosis / therapy*